Life › Medicine2 min read

Researchers find 11 shared T cell receptor families in data from 150,000 cancer patients, nine of them new

A pipeline applied to clinical genomics data from over 150,000 patients with advanced cancer found T cell receptors shared across patients. It points to routine clinical data as a source for immunotherapy discovery.

Researchers find 11 shared T cell receptor families in data from 150,000 cancer patients, nine of them new
Photo: Arora, Leena, and Durba Pal, Wikimedia Commons, CC BY 4.0 · License: CC BY 4.0

Researchers led by Emily Jackson have analysed data from more than 150,000 patients with advanced cancer and identified T cell receptors that are shared across multiple patients, according to a release published on EurekAlert on 4 November 2026. The work appeared in Science Translational Medicine the same day. The authors describe a pipeline for finding such "public" receptors. eurekalert.orgEurekAlerteurekalert.orgOpen source ↗

T cells carry receptors in their membranes that recognise tumour antigens, which makes the receptors a route to targeting tumour cells specifically. Scientists consider them a basis for new anticancer therapies. The difficulty, the authors note, is that T cell receptors are very diverse, and current discovery methods need labour-intensive workflows and tissue specimens that are hard to obtain. eurekalert.orgEurekAlerteurekalert.orgOpen source ↗

A database built from clinical genomics

The team assembled a database of bulk RNA sequencing data, clinical records and T cell receptor chains from more than 150,000 patients with more than 30 types of advanced cancer. They then developed an analytical pipeline to search through 26 million unique T cell receptor chains. eurekalert.orgEurekAlerteurekalert.orgOpen source ↗

Receptors tied to common antigens

The method found receptors associated with common cancer antigens, including mutated KRAS protein and human papillomavirus proteins. The authors also characterised 11 families of T cell receptors shared across multiple patient populations. Nine of these families were previously unknown. eurekalert.orgEurekAlerteurekalert.orgOpen source ↗

The study is computational and based on existing clinical data. The release does not report testing of these receptors as therapies. eurekalert.orgEurekAlerteurekalert.orgOpen source ↗

Jackson and colleagues conclude that patient-derived immune repertoires captured during routine clinical testing are a valuable and largely untapped resource for cancer immunotherapy discovery. The article is titled "Cancer-specific T cell receptor discovery using 150,000 clinical genomics samples" (DOI 10.1126/scitranslmed.aeh8192). eurekalert.orgEurekAlerteurekalert.orgOpen source ↗

Sources · 1

Found a mistake?
  1. ↩
Add RealTech as a preferred source in Google

Read also

Up next

The next story opens automatically

More
Follow us

Type at least two letters — results appear instantly

↑↓to choose↵to openescto close